Innovation in the Faculty of Medicine
In the news:
- Explore partnering with Sanofi Pasteur: Development and production of human vaccines, both prophylactic and therapeutic, including vaccines for chronic infectious diseases. Interest list here.
- NEW! ECHO (Entrepreneurship for Cardiovascular Health Opportunity) The Translational Biology & Engineering Program (TBEP) in partnership with the Health Innovation Hub (H2i) at the University of Toronto. ECHO is a specialized hands-on training program led by veteran entrepreneurs and consultants across a variety of sectors. ECHO provides innovators of cardiovascular technologies with entrepreneurship training, mentorship, networking, and funding opportunities. Any Canadian-based student, researcher and/or entrepreneur developing advanced cardiovascular technologies and innovations is encouraged to apply. Visit ECHO's website for full program information and enrolment instructions or contact Soror Sharifpoor, TBEP research program manager. Application deadline: August 24, 2018.
New resources for U of T Inventors and Entrepreneurs! The Innovations & Partnerships Office (IPO) is pleased to provide two new resources for faculty, researchers, and students interested in commercializing research or starting a company: The Inventor's Guide to Technology Transfer and the Start-Up Guide. These guides provide practical information on: When and how to disclose an invention; Protecting intellectual property; Navigating U of T policies and conflict of interest; Getting funding; and Bringing the technology to market. If you or your department have any questions or would like to host a workshop to learn more, contact firstname.lastname@example.org.
H2i Health Innovation Hub
H2i was established to create a culture and infrastructure that aligns, connects, serves and facilitates student driven translation of discoveries and ideas into problem-solving designs that impact positively on health matters. This mission of H2i is to enable, collaborate, educate, and facilitate student initiated commercialization of health matters.
H2i in the news:
- U of T to quicken pace of heart research commercialization with new entrepreneurhsip progam
- Industry experts are helping U of T health startups scale the 'brick wall' of regulatory approval
- Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
- Two H2I client companies – Xpan and 16 Bit – take top prizes at RBC Innovation & Entrepreneurship awards
- H2i venture ImmunoBiochem Corporation enters into collaboration with advanced Proteome Therapeutics to develop improved ADCs
- U of T startups take home prizes at health challenge event
- Medical startups compete for $15,000 in prizes at U of T accelerator's pitch event
CCDR Centre for Collaborative Drug Research
A multidisciplinary initiative bringing together the Faculty of Medicine, the Leslie Dan Faculty of Pharmacy and the Centre for Addiction and Mental Health, the CCDR is designed to spur networking, collaboration and innovation in drug research. The CCDR is actively involved in developing new models for collaboration and innovation with the pharmaceutical industry and other partners. The Centre’s initial areas of research focus include: New Targets in Neuroscience, Natural Products in Health & Disease, Pharmacogenomics & Drug Safety, and New Approaches to Anti-infective Therapy.
CCRM Centre for Commercialization of Regenerative Medicine
Many new and potentially life-changing RM-based treatments never reach patients because they are not successfully moved from the laboratory to a stage where they can be used in medicine. In order to fulfill RM’s promise to treat the many diseases affecting our population, a world-renowned group of stem cell scientists and bioengineers have come together to form CCRM. CCRM’s mission is to generate sustainable health and economic benefits through global collaboration in cell and gene therapy, and regenerative medicine.
CCAB Centre for Commercialization in Antibodies and Biologics
CCAB translates early stage biologics into high-value assets and products. Partners can access a robust portfolio of validated antibodies and biologics, powered by the University of Toronto’s antibody discovery engine, the Toronto Recombinant Antibody Centre (TRAC). From discovery and development to validation and licensing, CCAB reduces the time, risk, and costs associated with bringing new antibodies to market.
TBEP Translational Biology and Engineering Program
TBEP is the University of Toronto’s component of the Ted Rogers Centre for Heart Research (TRCHR). Occupying the 14th floor of MaRS Discovery District’s West Tower, TBEP brings together eight faculty members and their students from U of T Dentistry, Engineering and Medicine to advance heart research, diagnostics, and regeneration using a comprehensive approach that includes systems and developmental biology, technology innovation and clinical translation.
IBBME Institute of Biomaterials & Biomedical Engineering
IBBME researchers collaborate across the disciplines of engineering, medicine and dentistry to develop innovative solutions for the most pressing health-care challenges in the world. Learn about their four research themes in biomedical and clinical engineering that are shaping the next frontiers in human health.